Navigation Links
Gen-Probe Withdraws from Previously Announced Investor Presentations
Date:5/3/2012

SAN DIEGO, May 3, 2012 /PRNewswire/ -- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the Company has withdrawn from the following three upcoming investor conferences previously announced on April 26, 2012, and therefore will not webcast presentations at any of these investor conferences:

  • Deutsche Bank 37th Annual Health Care Conference in Boston on May 8 at 1:30 p.m. Eastern Time; 
  • Baird's 2012 Growth Stock Conference in Chicago on May 9 at 3:40 p.m. Central Time; and
  • Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas on May 15 at 4:20 p.m. Pacific Time.

(Logo:  http://photos.prnewswire.com/prnh/20120312/LA68580LOGO)

About Gen-Probe
Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. Gen-Probe is headquartered in San Diego and employs approximately 1,400 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions, or future events or performance are not historical facts and are forward-looking statements.  Forward-looking statements are not guarantees of performance.  They involve known and unknown risks, uncertainties and assumptions that may cause actual results to differ materially from those expressed or implied.  For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including our most recent Form 10-K, and all subsequent periodic filings.  We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro
Investor Relations
858-410-8904


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
2. Gen-Probe to Webcast Presentation at the 30th Annual J.P. Morgan Healthcare Conference
3. Gen-Probe to Webcast Presentation at the Oppenheimer 22nd Annual Healthcare Conference
4. Gen-Probe Announces Webcast of Second Quarter 2011 Earnings Conference Call
5. Gen-Probe to Webcast Presentation at the William Blair & Company 31st Annual Growth Stock Conference
6. Gen-Probe Files for US Regulatory Clearance of PANTHER™ System, Fully Automated and Integrated Molecular Testing Instrument
7. Gen-Probe Reports Financial Results for the First Quarter of 2011
8. Gen-Probe to Webcast Three Upcoming Investor Presentations
9. Gen-Probe Announces $150 Million Stock Repurchase Plan
10. Gen-Probe to Webcast Two Upcoming Investor Presentations
11. Gen-Probe Announces Webcast of Third Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Januar 2017  ResMed (NYSE: RMD ), ... Medical ( Winter Haven, Florida ) gaben ... die Beilegung aller globalen Rechtsstreitigkeiten zwischen den Parteien geeinigt ... ihrer bestehenden Produkte im Tausch gegen Lizenzgebühren an ResMed ... leisten, um das in Florida ...
(Date:1/22/2017)... DAVOS, Switzerland and ABU DHABI , ... leaders from the US ... , Hospital of the Future , at ... in the hospital of the future will be driven by big data and ... better," according to the panel of experts that discussed the ,Hospital of the ...
(Date:1/21/2017)... Mass. , Jan. 20, 2017 /PRNewswire/ ... Keystone Symposia Conference, "PI3K Pathways in Immunology, ... Inc. (NASDAQ: INFI ) ... immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase-gamma ... able to help overcome resistance to checkpoint ...
Breaking Medicine Technology:
(Date:1/22/2017)... ... ... Zifam Pinnacle, an Australian company dedicated to providing a unique range of ... the January ECRM Trade Show in Hilton Head, SC. , Zifam Pinnacle develops products ... of its creations to help create a more traditional and natural approach to healthy ...
(Date:1/21/2017)... ... 2017 , ... Caronlab Australia, an Australian company known for health and beauty ... Head, SC, where it benefited from outstanding meetings with major retail buyers. , Caron ... products. At this trade show, the company had the chance to demonstrate its products ...
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats ... of its owner and founder. As Oat is recognized globally as one of the ... personally as he believes it is a move to sow the seed of good ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... Redwood Family Dermatology has recently joined their multi-specialty medical group. The ... range of cosmetic services. , “We’re excited to add this excellent dermatology practice ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Periodontist Dr. Dan Holtzclaw in media for its creos™ line of bone regenerative ... by Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a ...
Breaking Medicine News(10 mins):